Global Pharmaceutical Sterile Fill-Finish Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Pharmaceutical Sterile Fill-Finish Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
In pharmaceutical manufacturing, fill-finish operations are critical, since fill-finish is the last step before a product is packaged and ultimately delivered to the patient. By the time a drug reaches this stage, the drug product is highly valuable, as it has already been through labour- and cost-intensive production stages, including upstream processing, cell culture or fermentation and downstream purification. Failures in the integrity of the fill-finish stage can introduce microbial contamination and generate issues with formulation and dosing.
Pharmaceutical Sterile Fill-Finish report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmaceutical Sterile Fill-Finish market is projected to reach US$ 4659.6 million in 2034, increasing from US$ 3309 million in 2022, with the CAGR of 5.1% during the period of 2024 to 2034. Demand from Vaccines and Biologics and Biosimilar are the major drivers for the industry.
Baxter BioPharma Solutions is one of the most important global key players of pharmaceutical sterile fill-finish, holds a share of about 10%, other key players include Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, etc. America is the largest market, occupied for about 40 percent, followed by Europe. In terms of type, vials are the largest segment, with a share of about 70%, and in terms of application, the vaccines segment holds a share of over 50 percent.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical Sterile Fill-Finish market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Segment by Type
Vials
Prefilled Syringes
Cartridges
Others
Vaccines
Biologics and Biosimilar
Generics
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical Sterile Fill-Finish market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pharmaceutical Sterile Fill-Finish introduction, etc. Pharmaceutical Sterile Fill-Finish Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Pharmaceutical Sterile Fill-Finish market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Pharmaceutical Sterile Fill-Finish report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pharmaceutical Sterile Fill-Finish market is projected to reach US$ 4659.6 million in 2034, increasing from US$ 3309 million in 2022, with the CAGR of 5.1% during the period of 2024 to 2034. Demand from Vaccines and Biologics and Biosimilar are the major drivers for the industry.
Baxter BioPharma Solutions is one of the most important global key players of pharmaceutical sterile fill-finish, holds a share of about 10%, other key players include Boehringer Ingelheim, Vetter Pharma, Fresenius Kabi, etc. America is the largest market, occupied for about 40 percent, followed by Europe. In terms of type, vials are the largest segment, with a share of about 70%, and in terms of application, the vaccines segment holds a share of over 50 percent.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pharmaceutical Sterile Fill-Finish market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Segment by Type
Vials
Prefilled Syringes
Cartridges
Others
Segment by Application
Vaccines
Biologics and Biosimilar
Generics
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pharmaceutical Sterile Fill-Finish market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Pharmaceutical Sterile Fill-Finish introduction, etc. Pharmaceutical Sterile Fill-Finish Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Pharmaceutical Sterile Fill-Finish market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.